The Scientist - Home

A pill is shown on a blue technical background. One half of the pill has a DNA helix on it, and the other half has a depiction of a computer chip, representing the role of artificial intelligence in drug development.
| 3 min read
2026 will be the year that artificial intelligence accelerates multiple aspects of the drug discovery and development pipeline, industry leaders predict.

Latest

The Scientist Placeholder Image

University Briefs

The Scientist Placeholder Image

Independent Lab Briefs

The Scientist Placeholder Image

U. K. Scientists Fear Government Will Muzzle Research Reports

The Scientist Placeholder Image

Entrepreneur Briefs

The Scientist Placeholder Image

Industry Briefs

The Scientist Placeholder Image

Low Profile for SDI Work on Campus

The Scientist Placeholder Image

FASEB Offers Four Themes at Annual Meeting

The Scientist Placeholder Image

Internal Strains Block Joint Biotech Research

The Scientist Placeholder Image

Some LEAP at Chance to Forge Teams

The Scientist Placeholder Image

A Botanist In Newspaperland

The Scientist Placeholder Image

The Rehabilitation of N.I. Bukharin

The Scientist Placeholder Image

Baruch Blumberg: Science on TV

Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies